ABVC BioPharma Long Term Debt

ABVC BioPharma (ABVC) currently reports a long-term debt of $1.4M as of June 2026. That compares with $180K in the prior-year period — up 693.5% year over year. Use the charts on this page to explore ABVC BioPharma's long-term debt history and peer comparisons.

ABVC BioPharma's long-term debt increased from $180K to $1.4M — a 693.5% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ABVC BioPharma reported $1.4M in long-term debt as of June 2026. That compares with $180K in the prior-year period — up 693.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $1.4M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ABVC BioPharma, and consider following ABVC for alerts when major investors trade the stock.

ABVC BioPharma is classified in the Industrials sector. On long-term debt, it currently shows $1.4M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Industrials are usually more informative than comparing ABVC with unrelated industries.